Larvol Delta - BioAge-Labs-completes-INDenabling-studies-for-BGE102-a-potent-orally-available-brainpenetrant-NLRP3-inhibitor-and-advances-candidate-toward-the-clinic

BGE-102 - BioAge Labs

https://www.globenewswire.com/news-release/2025/05/29/3090396/0/en/BioAge-Labs-completes-IND-enabling-studies-for-BGE-102-a-potent-orally-available-brain-penetrant-NLRP3-inhibitor-and-advances-candidate-toward-the-clinic.html

May 29, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next